GlassScriptPhysician profile
Kiarash Michel
NPI 1255390464
$7,466.08
in general payments reported to CMS, 2019-2025
51 companies · $1,633 in 2025
The $1,633 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $169 · 2021: $896 · 2022: $1,151 · 2023: $1,571 · 2024: $1,552 · 2025: $1,633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,607 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,607.31 |
| Education | $148.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $851.91 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $778.59 | 2020-2025 | Prolaris, Myrisk |
| Antares Pharma, INC. | $580.59 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $547.41 | 2019-2025 | Erleada, Balversa, Akeega |
| Astellas Pharma US INC | $367.64 | 2019-2025 | Xtandi |
| Urogen Pharma, INC. | $316.84 | 2021-2025 | Jelmyto |
| Pfizer INC. | $253.71 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $248.66 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $242.60 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Verity Pharmaceuticals INC. | $238.24 | 2024-2025 | Tlando, Trelstar |
| Rochester Medical Corporation | $214.00 | 2022 | |
| Blue Earth Diagnostics | $200.65 | 2019-2025 | Posluma |
| Allergan, INC. | $199.34 | 2019-2021 | |
| Profound Medical Corp. | $192.69 | 2021-2023 | Tulsa-Pro |
| Boston Scientific Corporation | $180.29 | 2019-2024 | Rezum Generator |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $172.99 | 2021-2025 | Urolift, Solesta, Barrigel |
| Progenics Pharmaceuticals, INC. | $172.86 | 2022-2025 | Pylarify |
| Telix Pharmaceuticals | $162.65 | 2023-2025 | Illuccix |
| Dendreon Pharmaceuticals LLC | $125.47 | 2023-2025 | Provenge |
| Immunitybio, INC. | $102.74 | 2024-2025 | |
| Tolmar, INC. | $85.57 | 2023-2024 | |
| Coloplast Corp | $84.90 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $76.01 | 2023-2025 | Gemtesa, Orgovyx |
| Edap Technomed INC | $75.00 | 2022 | |
| Becton, Dickinson and Company | $69.88 | 2024 | Bard Urinary Drainage Bag |
| Procept Biorobotics Corporation | $67.89 | 2024-2025 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $61.46 | 2019-2025 | Adstiladrin |
| Acerus Pharmaceuticals Corporation | $61.23 | 2021-2022 | |
| Cycle Pharmaceuticals INC | $60.61 | 2025 | Venxxiva |
| 180 Medical, INC. | $59.78 | 2023-2024 | Gentlecath Glide |
| Endo USA, INC. | $51.17 | 2025 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $49.42 | 2023 | Bard Urinary Drainage Bag |
| Baxter Healthcare | $44.39 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $41.12 | 2021 | |
| Axonics, INC. | $40.72 | 2023-2024 | Axonics, Bulkamid |
| Laborie Medical Technologies Corp. | $40.52 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Koelis INC. | $39.90 | 2023 | |
| Halozyme INC | $39.54 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $34.33 | 2024 | |
| Endo Pharmaceuticals INC. | $32.33 | 2019-2024 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $30.80 | 2025 | |
| Caris Mpi, INC. | $24.32 | 2025 | Mi Cancer Seek |
| Hollister Incorporated | $22.13 | 2019 | |
| Olympus America INC. | $21.07 | 2025 | Uropass |
| Aytu Biopharma, INC. | $20.04 | 2020 | |
| Angiodynamics, INC. | $17.76 | 2025 | Nanoknife |
| Sagent Pharmaceuticals | $17.12 | 2023 | Glydo |
| Metuchen Pharmaceuticals | $16.32 | 2019 | |
| Medtronic, INC. | $15.83 | 2021 | |
| Medtronic USA, INC. | $15.05 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiarash Michel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.